The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

about

Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2- metastatic breast cancer.

P2860

Q38661473-D74E504E-2BAE-452E-9EBB-F3655DEAB3B4

P2860

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

Item

http://www.wikidata.org/entity/Q41747966

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

@en

type

Item

label

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

@en

prefLabel

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

@en

P1476

The Changing Landscape of Breast Cancer: How Biology Drives Therapy

@en

P2093

Sarah Friend

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Comprehensive molecular portraits of human breast tumours

Development of cell-cycle checkpoint therapy for solid tumors

Effectiveness and safety of poly (ADP-ribose) polymerase inhibitors in cancer therapy: A systematic review and meta-analysis

PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application

Trastuzumab emtansine for HER2-positive advanced breast cancer.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

P31

scholarly article

P356

10.3390/MEDICINES3010002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melanie Royce

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291529655

http://www.w3.org/2001/XMLSchema#string

P698

28930112

http://www.w3.org/2001/XMLSchema#string

P932

5456232

http://www.w3.org/2001/XMLSchema#string

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

about

P2860

P2860

The Changing Landscape of Breast Cancer: How Biology Drives Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P5875

P698

P932